Notably, CD9 exhibited differential expression in tumor-associated macrophages (TAMs), and CellChat-predicted enhanced TGF-β signaling suggests its role in modulating tumor-immune crosstalk, warranting validation via spatial transcriptomics or multiplex immunofluorescence. This evidence concerns the gene CD9 and neoplasm.